带有细胞外囊泡的光交联粘合水凝促进血液静止和肝脏再生
Wuzheng Xia1, Guanzhi Lai1,2, Yichuan Li3
1Department of Organ Transplantation, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, Guangzhou, China.
Frontiers in bioengineering and biotechnology
|May 26, 2023
概括
这项研究开发了一种用于肝脏手术的新型复合水凝敷料. 用干细胞外体增强的GelMA/Alg-DA-1水凝对肝脏血液静止和再生有很大的前景.
科学领域:
- 生物材料科学 生物材料科学
- 再生医学是一种再生医学.
- 手术创新 在外科创新.
背景情况:
- 肝脏疾病的肝切除术在控制出血和确保术后肝功能方面存在挑战.
- 现有的治疗方法缺乏最佳的解决方案,以进行手术内静血和促进肝脏组织再生.
研究的目的:
- 设计一种复合水凝敷料,具有卓越的静血能力,生物相容性和肝细胞再生潜力.
- 为了研究不同酸盐-多巴胺度对水凝特性的影响.
- 为了评估结合脂肪衍生的介质干细胞外生体 (AD-MSC-Exo) 增强肝脏再生的疗效.
主要方法:
- 通过UV交叉连接制造具有不同Alg-DA度 (0.5%,1%,2%) 的GelMA/Alg-DA复合水凝.
- 水凝的孔隙性,机械性质 (弹性模量),吸水性,粘附性和压缩性的特征.
- 在体外评估可降解性,生物相容性,静血功能,促进细胞增殖和迁移.
主要成果:
- 复合水凝表现出多孔结构 (>65%的多孔性) 和增强的物理化学性质与增加的Alg-DA含量.
- 凝MA/Alg-DA-1水凝在可降解性,生物相容性和静血性方面表现最佳.
- 与对照组相比,装载AD-MSC-Exo的GelMA/Alg-DA-1水凝显著促进了细胞的增殖和迁移.
结论:
- 凝MA/Alg-DA-1复合液凝为肝脏伤口血静提供了一个有前途的平台.
- 加入AD-MSC-Exo进一步提高了用于肝脏应用的水凝的再生能力.
- 这种复合水凝具有显著的潜力,可以改善肝脏手术和再生的结果.
更多相关视频
相关概念视频
01:24Liver Regeneration
3.3K
The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
3.3K
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K